| Fund ID | 805-2332087528 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 99% |
| Fund | Type | Gross assets |
|---|---|---|
| Sv Life Sciences Fund IV Cf, L.P. | Venture Capital | $412.1M |
| Sv Life Sciences Fund VI, L.P. | Venture Capital | $224.7M |
| Sv Life Sciences Fund V, L.P. | Venture Capital | $138.5M |
Medtech Convergence Fund, L.P. reports $75 million in gross assets, among the top 47% of private funds by size.
Medtech Convergence Fund, L.P. is managed by Sv Health Investors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.